{Reference Type}: Journal Article
{Title}: Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.
{Author}: Ono Y;Tadokoro K;Yunoki T;Yamashita T;Sato D;Sato H;Akamatsu S;Mizukami H;Ohta Y;Yamano Y;Kimura A;Shimohata T;
{Journal}: Parkinsonism Relat Disord
{Volume}: 124
{Issue}: 0
{Year}: 2024 Jul 30
{Factor}: 4.402
{DOI}: 10.1016/j.parkreldis.2024.106992
{Abstract}: BACKGROUND: Anti-immunoglobulin-like cell adhesion molecule 5 (IgLON5) disease is a rare autoimmune encephalitis that can mimic progressive supranuclear palsy or corticobasal syndrome. Moreover, anti-IgLON5 disease can present with symptoms characteristic of multiple system atrophy (MSA), such as cerebellar ataxia and autonomic dysfunction. However, the clinical features of anti-IgLON5 disease resembling MSA have not been well established.
METHODS: We enrolled 35 patients with suspected MSA for whom anti-IgLON5 antibody tests were requested. We evaluated immunoglobulin G (IgG) against IgLON5 using cell-based assays. We also summarized the clinical characteristics of patients who were positive for anti-IgLON5 antibodies.
RESULTS: We identified serum and cerebrospinal fluid anti-IgLON5 antibodies in three patients. These patients had many clinical features characteristic of MSA, including parkinsonism, cerebellar ataxia, severe orthostatic hypotension, acute respiratory failure, sleep parasomnia, vocal cord paralysis, and pyramidal tract signs. Clinical features atypical for MSA were myorhythmia, horizontal eye movement restriction, fasciculations, and painful muscle cramps.
CONCLUSIONS: Anti-IgLON5 disease may be an important differential diagnosis of MSA. A comprehensive physical examination, including assessments of eye movement, lower motor neuron signs, and atypical involuntary movements, is important to avoid misdiagnosis.